Spontaneous intracerebral hemorrhage: a review of the prevalence, trigger factors, therapeutic and surgical treatment

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Spontaneous intracerebral hemorrhage is the second most common subtype of stroke and is a significant cause of mortality and morbidity worldwide. Trigger factors that “accelerate” disease onset may include hypertension, excessive alcohol consumption, constant smoking, hypocholesterolemia, medications, male sex, advanced age, living in an underdeveloped country, ethnicity, chronic kidney disease, cerebral amyloid angiopathy, and microhemorrhages.

Therapeutic solutions for spontaneous intracerebral hemorrhage aimed at stopping the progression of hemorrhage, reducing the clot volume of intraventricular and parenchymal hematoma, combating perihematomal edema and inflammation, rapidly reducing blood pressure, and providing hemostatic therapy with transfusion of platelets and other coagulation complexes.

Clinical trials on minimally invasive methods of surgical evacuation (endoscopic surgery, stereotactic aspiration, and invasive craniopuncture) are ongoing and may provide positive results because of the shorter operation time and use of local anesthesia. Minimally invasive surgery methods can theoretically improve the outcomes of open surgery by reducing damage to collateral tissues and reducing anesthesia time; however, they cannot be a full-fledged alternative.

Full Text

Restricted Access

About the authors

Kenan S. Niftaliev

N.N. Burdenko Voronezh State Medical University

Author for correspondence.
Email: niftaliev@yahoo.com
ORCID iD: 0000-0002-6996-4188
SPIN-code: 1877-7033
Russian Federation, Voronezh

References

  1. Puy L, Parry-Jones AR, Sandset EC, et al. Intracerebral haemorrhage. Nature Reviews Disease Primers. 2023;9(1):14. doi: 10.1038/s41572-023-00424-7
  2. O’Carroll CB, Brown BL, Freeman WD. Intracerebral hemorrhage: a common yet disproportionately deadly stroke subtype. Mayo Clin Proc. 2021;96(6):1639–1654. doi: 10.1016/j.mayocp.2020.10.034
  3. Stefanou MI, Giannopapas V, Kitsos DK, et al. Prevalence and epidemiology of stroke in patients with multiple sclerosis: a systematic review and meta-analysis. J Neurol. doi: 10.1007/s00415-024-12331-2
  4. On S, Poh R, Salor RS, et al. The burden and risks factors for intracerebral hemorrhage in a Southeast Asian population. Clin Neurol Neurosurg. 2022;214:107145. doi: 10.1016/j.clineuro.2022.107145
  5. Sun T, Yuan Y, Wu K, et al. Trends and patterns in the global burden of intracerebral hemorrhage: a comprehensive analysis from 1990 to 2019. Front Neurol. 2023;14:1241158. doi: 10.3389/fneur.2023.1241158
  6. Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355–369. doi: 10.1016/S1474-4422(09)70025-0
  7. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38(6):2001–2023. doi: 10.1161/STROKEAHA.107.183689
  8. Toyoda K. Epidemiology and registry studies of stroke in Japan. J Stroke. 2013;15(1):21–26. doi: 10.5853/jos.2013.15.1.21
  9. Hong KS, Bang OY, Kang DW, et al. Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke. J Stroke. 2013;15(1):2–20. doi: 10.5853/jos.2013.15.1.2
  10. Flaherty ML, Woo D, Haverbusch M, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005;36(5): 934–937. doi: 10.1161/01.STR.0000160756.72109.95
  11. Jolink WM, Klijn CJ, Brouwers PJ, et al. Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage. Neurology. 2015;85(15):1318–1324. doi: 10.1212/WNL.0000000000002015
  12. Stein M, Misselwitz B, Hamann GF, et al. Intracerebral hemorrhage in the very old: future demographic trends of an aging population. Stroke. 2012;43(4):1126–1128. doi: 10.1161/STROKEAHA.111.644716
  13. Xia C, Hoffman H, Anikpezie N, et al. Trends in the incidence of spontaneous subarachnoid hemorrhages in the United States, 2007–2017. Neurology. 2023;100(2):e123–e132. doi: 10.1212/WNL.0000000000201340
  14. Bako AT, Pan AP, Potter T, et al. Demographic characteristics and clinical outcomes of asian american and pacific islander patients with primary intracerebral hemorrhage. JAMA Netw Open. 2021;4(12):e2138786. doi: 10.1001/jamanetworkopen.2021.38786
  15. Gabriele F, Foschi M, Conversi F, et al. Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry. Int J Stroke. 2023. doi: 10.1177/17474930231218594
  16. Ferrete-Araujo AM, Egea-Guerrero JJ, Vilches-Arenas Á, et al. Predictors of mortality and poor functional outcome in severe spontaneous intracerebral hemorrhage: a prospective observational study. Med Intensiva. 2015;39(7):422–432. doi: 10.1016/j.medin.2014.10.008
  17. Tahara S, Hattori Y, Aso S, et al. Trends in surgical procedures for spontaneous intracerebral hemorrhage in Japan. J Stroke Cerebrovasc Dis. 2022;31(9):106664. doi: 10.1016/j.jstrokecerebrovasdis.2022.106664
  18. Wang P, Sun Y, Yi D, et al. Clinical features of Chinese patients in different age groups with spontaneous intracerebral hemorrhage based on multicenter inpatient information. Neurol Res. 2020;42(8):657–664. doi: 10.1080/01616412.2020.1782082
  19. Faghih-Jouybari M, Raof MT, Abdollahzade S, et al. Mortality and morbidity in patients with spontaneous intracerebral hemorrhage: a single-center experience. Curr J Neurol. 2021;20(1):32–36. doi: 10.18502/cjn.v20i1.6377
  20. Talha KA, Selina F, Patwary MI, et al. Relationship between cholesterol level and spontaneous intracerebral hemorrhage: a case-control study in Bangladesh. Mymensingh Med J. 2022;31(4):1115–1120.
  21. Sun W, Germans MR, Sebök M, et al. Outcome comparison between surgically treated brain arteriovenous malformation hemorrhage and spontaneous intracerebral hemorrhage. World Neurosurg. 2020;139:e807–e811. doi: 10.1016/j.wneu.2020.04.170
  22. Pasi M, Casolla B, Kyheng M, et al. Long-term functional decline of spontaneous intracerebral haemorrhage survivors. J Neurol Neurosurg Psychiatry. 2021;92(3):249–254. doi: 10.1136/jnnp-2020-324741
  23. Li X, Zhang L, Wolfe CDA, Wang Y. Incidence and long-term survival of spontaneous intracerebral hemorrhage over time: a systematic review and meta-analysis. Front Neurol. 2022;13:819737. doi: 10.3389/fneur.2022.819737
  24. Bakhtiyarova AB, Grigorova KA. Spontaneous intracranial hemorrhages. Risk factors. Izvestia of the Russian Military Medical Academy. 2020;39(S1-2):28–30. EDN: EXYAIY
  25. van Etten ES, Kaushik K, Jolink WMT, et al. Trigger factors for spontaneous intracerebral hemorrhage: a case-crossover study. Stroke. 2022;53(5):1692–1699. doi: 10.1161/STROKEAHA.121.036233
  26. Martini SR, Flaherty ML, Brown WM, et al. Risk factors for intracerebral hemorrhage differ according to hemorrhage location. Neurology. 2012;79(23):2275–2282. doi: 10.1212/WNL.0b013e318276896f
  27. Carpenter A, Singh I, Gandhi C, Prestigiacomo CJ. Genetic risk factors for spontaneous intracerebral haemorrhage. Nat Rev Neurol. 2016;12(1):40–49. doi: 10.1038/nrneurol.2015.226
  28. Sturgeon JD, Folsom AR, Longstreth WT Jr, et al. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38(10):2718–2725. doi: 10.1161/STROKEAHA.107.487090
  29. O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a casecontrol study. Lancet. 2010;376(9735):112–123. doi: 10.1016/S0140-6736(10)60834-3
  30. Li S, Wang Y, Wang W, et al. Stress hyperglycemia is predictive of clinical outcomes in patients with spontaneous intracerebral hemorrhage. BMC Neurol. 2022;22(1):236. doi: 10.1186/s12883-022-02760-9
  31. Larsen KT, Selseth MN, Jahr SH, et al. Prehospital blood pressure and clinical and radiological outcomes in acute spontaneous intracerebral hemorrhage. Stroke. 2022;53(12):3633–3641. doi: 10.1161/STROKEAHA.121.038524
  32. Feng H, Wang X, Wang W, Zhao X. Risk factors and a prediction model for the prognosis of intracerebral hemorrhage using cerebral microhemorrhage and clinical factors. Front Neurol. 2023;14:1268627. doi: 10.3389/fneur.2023.1268627
  33. Sallinen H, Pietilä A, Salomaa V, Strbian D. Risk factors of intracerebral hemorrhage: a case-control study. J Stroke Cerebrovasc Dis. 2020;29(4):104630. doi: 10.1016/j.jstrokecerebrovasdis.2019.104630
  34. Mustanoja S, Strbian D, Putaala J, et al. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage. Stroke. 2013;44(8):2330–2332. doi: 10.1161/STROKEAHA.113.001829
  35. Flaherty ML, Tao H, Haverbusch M, et al. Warfarin use leads to larger intracerebral hematomas. Neurology. 2008;71(14):1084–1089. doi: 10.1212/01.wnl.0000326895.58992.27
  36. Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68(2):116–121. doi: 10.1212/01.wnl.0000250340.05202.8b
  37. An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017;19(1):3–10. doi: 10.5853/jos.2016.00864
  38. Gil-Garcia CA, Flores-Alvarez E, Cebrian-Garcia R, et al. Essential topics about the imaging diagnosis and treatment of hemorrhagic stroke: a comprehensive review of the 2022 AHA guidelines. Curr Probl Cardiol. 2022;47(11):101328. doi: 10.1016/j.cpcardiol.2022.101328
  39. Ovbiagele B, Wing JJ, Menon RS, et al. Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage. Stroke. 2013;44(9):2409–2413. doi: 10.1161/STROKEAHA.113.001958
  40. Goos JD, Henneman WJ, Sluimer JD, et al. Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology. 2010;74(24):1954–1960. doi: 10.1212/WNL.0b013e3181e396ea
  41. Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke. 2013;44(4):995–1001. doi: 10.1161/STROKEAHA.111.000038
  42. Yung SY, Bae HJ, Park BJ, et al. Parity and risk of hemorrhagic strokes. Neurology. 2010;74(18):1424–1429. doi: 10.1212/WNL.0b013e3181dc13a5
  43. Kim BJ, Lee SH, Ryu WS, et al. Excessive work and risk of haemorrhagic stroke: a nationwide case-control study. Int J Stroke. 2013;8 Suppl. A100:56–61. doi: 10.1111/j.1747-4949.2012.00949.x
  44. Kim TJ, Kim CK, Kim Y, et al. Prolonged sleep increases the risk of intracerebral haemorrhage: a nationwide case-control study. Eur J Neurol. 2016;23(6):1036–1043. doi: 10.1111/ene.12978
  45. Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293–298. doi: 10.1016/S0140-6736(07)60151-2
  46. Kok YE, Pszczolkowski S, Law ZK, et al. Semantic segmentation of spontaneous intracerebral hemorrhage, intraventricular hemorrhage, and associated edema on CT images using deep learning. Radiol Artif Intell. 2022;4(6):e220096. doi: 10.1148/ryai.220096
  47. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947. doi: 10.1161/STR.0b013e318284056a
  48. Andrews CM, Jauch EC, Hemphill JC 3rd, et al. Emergency neurological life support: intracerebral hemorrhage. Neurocrit Care. 2012;17 Suppl 1:S37–S46. doi: 10.1007/s12028-012-9757-2
  49. Sakamoto Y, Koga M, Yamagami H, et al. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. Stroke. 2013;44(7):1846–1851. doi: 10.1161/STROKEAHA.113.001212
  50. Kirshner H, Schrag M. Management of intracerebral hemorrhage: update and future therapies. Curr Neurol Neurosci Rep. 2021;21(10):57. doi: 10.1007/s11910-021-01144-9
  51. Butcher KS, Jeerakathil T, Hill M, et al. The intracerebral hemorrhage acutely decreasing arterial pressure trial. Stroke. 2013;44(3):620–626. doi: 10.1161/STROKEAHA.111.000188
  52. Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–2365. doi: 10.1056/NEJMoa1214609
  53. Qureshi AI, Palesch YY, Foster LD, et al. Blood pressure-attained analysis of ATACH 2 Trial. Stroke. 2018;49(6):1412–1418. doi: 10.1161/STROKEAHA.117.019845
  54. Moullaali TJ, Wang X, Martin RH, et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 2019;18(9):857–864. doi: 10.1016/S1474-4422(19)30196-6
  55. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7(5):391–399. doi: 10.1016/S1474-4422(08)70069-3
  56. Flynn RW, MacDonald TM, Murray GD, et al. Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke. 2010;41(11):2606–2611. doi: 10.1161/STROKEAHA.110.589143
  57. Divani AA, Liu X, Di Napoli M, et al. Blood pressure variability predicts poor in-hospital outcome in spontaneous intracerebral hemorrhage. Stroke. 2019;50(8):2023–2029. doi: 10.1161/STROKEAHA.119.025514
  58. Adeoye O, Broderick JP. Advances in the management of intracerebral hemorrhage. Nat Rev Neurol. 2010;6(11):593–601. doi: 10.1038/nrneurol.2010.146
  59. Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033–1043. doi: 10.1056/NEJMoa1603460
  60. Thompson BB, Bejot Y, Caso V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75(15):1333–1342. doi: 10.1212/WNL.0b013e3181f735e5
  61. Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387(10038):2605–2613. doi: 10.1016/S0140-6736(16)30392-0
  62. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349(11):1019–1026. doi: 10.1056/NEJMoa022913
  63. Kuramatsu JB, Gerner ST, Schellinger PD, et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 2015;313(8):824–836. doi: 10.1001/jama.2015.0846
  64. Goldstein JN, Refaai MA, Milling TJ Jr, et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet. 2015;385(9982):2077–2087. doi: 10.1016/S0140-6736(14)61685-8
  65. Purrucker JC, Haas K, Rizos T, et al. Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants. JAMA Neurol. 2016;73(2): 169–177. doi: 10.1001/jamaneurol.2015.3682
  66. Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019;266(12):3126–3135. doi: 10.1007/s00415-019-09536-1
  67. Pollack CV Jr, Reilly PA, van Ryn J, et al. Idarucizumab for dabigatran reversal — full cohort analysis. N Engl J Med. 2017;377(5):431–441. doi: 10.1056/NEJMoa1707278
  68. Connolly SJ, Milling TJ Jr, Eikelboom JW, et al. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375(12):1131–1141. doi: 10.1056/NEJMoa1607887
  69. Sprigg N, Flaherty K, Appleton JP, et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;391(10135):2107–2115. doi: 10.1016/S0140-6736(18)31033-X
  70. Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9(7):840–855. doi: 10.1111/ijs.12309
  71. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7): 2032–2060. doi: 10.1161/STR.0000000000000069
  72. Tran H, Joseph J, Young L, et al. New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis. Intern Med J. 2014;44(6):525–536. doi: 10.1111/imj.12448
  73. Al-Shahi Salman R, Stephen J, Tierney JF, et al. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials. Lancet Neurol. 2023;22(12):1140–1149. doi: 10.1016/S1474-4422(23)00315-0
  74. Majeed A, Kim YK, Roberts RS, et al. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010;41(12): 2860–2866. doi: 10.1161/STROKEAHA.110.593087
  75. Schulman S. Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: no. Stroke. 2011;42(12): 3663–3664. doi: 10.1161/STROKEAHA.111.621813
  76. ACTIVE Investigators; Connolly SJ, Pogue J, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360(20):2066–2078. doi: 10.1056/NEJMoa0901301
  77. Naidech AM, Jovanovic B, Liebling S, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009;40(7): 2398–2401. doi: 10.1161/STROKEAHA.109.550939
  78. Sansing LH, Messe SR, Cucchiara BL, et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology. 2009;72(16):1397–1402. doi: 10.1212/01.wnl.0000342709.31341.88
  79. de Gans K, de Haan RJ, Majoie CB, et al. PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol. 2010;10:19. doi: 10.1186/1471-2377-10-19
  80. Da Pian R, Bazzan A, Pasqualin A. Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases. Neurol Res. 1984;6(3):145–151. doi: 10.1080/01616412.1984.11739680
  81. Firsching R, Huber M, Frowein RA. Cerebellar haemorrhage: management and prognosis. Neurosurg Rev. 1991;14(3):191–194. doi: 10.1007/BF00310656
  82. Kittiwattanagul W, Namwaing P, Khamsai S, Sawanyawisuth K. Clinical characteristics and outcomes of patients with intracerebral hemorrhage: nonsurgical versus surgical treatment. J Emerg Trauma Shock. 2023;16(4):145–149. doi: 10.4103/jets.jets_55_23
  83. Kellner CP, Chartrain AG, Nistal DA, et al. The stereotactic intracerebral hemorrhage underwater blood aspiration (SCUBA) technique for minimally invasive endoscopic intracerebral hemorrhage evacuation. J Neurointerv Surg. 2018;10(8):771–776. doi: 10.1136/neurintsurg-2017-013719
  84. Hanley DF, Thompson RE, Muschelli J, et al. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016;15(12):1228–1237. doi: 10.1016/S1474-4422(16)30234-4
  85. Ibrahim A, Arifianto MR, Al Fauzi A. Minimally invasive neuroendoscopic surgery for spontaneous intracerebral hemorrhage: a review of the rationale and associated complications. Acta Neurochir Suppl. 2023;130:103–108. doi: 10.1007/978-3-030-12887-6_13
  86. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365(9457):387–397. doi: 10.1016/S0140-6736(05)17826-X
  87. Mendelow AD, Gregson BA, Rowan EN, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382(9890):397–408. Corrected and republished from: Lancet. 2013;382(9890):396. doi: 10.1016/S0140-6736(13)60986-1
  88. Sondag L, Schreuder FHBM, Boogaarts HD, et al. Neurosurgical Intervention for Supratentorial Intracerebral Hemorrhage. Ann Neurol. 2020;88(2):239–250. doi: 10.1002/ana.25732
  89. Lo YT, See AAQ, King NKK. Decompressive craniectomy in spontaneous intracerebral hemorrhage: a case-control study. World Neurosurg. 2017;103:815–820.e2. doi: 10.1016/j.wneu.2017.04.025
  90. Heuts SG, Bruce SS, Zacharia BE, et al. Decompressive hemicraniectomy without clot evacuation in dominant-sided intracerebral hemorrhage with ICP crisis. Neurosurg Focus. 2013;34(5):E4. doi: 10.3171/2013.2.FOCUS1326
  91. Esquenazi Y, Savitz SI, El Khoury R, et al. Decompressive hemicraniectomy with or without clot evacuation for large spontaneous supratentorial intracerebral hemorrhages. Clin Neurol Neurosurg. 2015;128:117–122. doi: 10.1016/j.clineuro.2014.11.015
  92. Shi J, Cai Z, Han W, et al. Stereotactic catheter drainage versus conventional craniotomy for severe spontaneous intracerebral hemorrhage in the basal ganglia. Cell Transplant. 2019;28(8): 1025–1032. doi: 10.1177/0963689719852302
  93. Zhou X, Chen J, Li Q, et al. Minimally invasive surgery for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis of randomized controlled trials. Stroke. 2012;43(11): 2923–2930. doi: 10.1161/STROKEAHA.112.667535
  94. Scaggiante J, Zhang X, Mocco J, Kellner CP. Minimally invasive surgery for intracerebral hemorrhage. Stroke. 2018;49(11): 2612–2620. doi: 10.1161/STROKEAHA.118.020688
  95. Carhuapoma JR, Barrett RJ, Keyl PM, et al. Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema. Neurocrit Care. 2008;8(3):322–329. doi: 10.1007/s12028-008-9074-y
  96. Atiyeh B, Ghieh F, Oneisi A. Safety and efficiency of minimally invasive buttock augmentation: a review. Aesthetic Plast Surg. 2023;47(1):245–259. doi: 10.1007/s00266-022-03049-5
  97. Hanley DF, Thompson RE, Rosenblum M, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393(10175): 1021–1032. Corrected and republished from: Lancet. 2019; 393(10181):1596. doi: 10.1016/S0140-6736(19)30195-3
  98. Awad IA, Polster SP, Carrión-Penagos J, et al. Surgical performance determines functional outcome benefit in the minimally invasive surgery plus recombinant tissue plasminogen activator for intracerebral hemorrhage evacuation (MISTIE) procedure. Neurosurgery. 2019;84(6):1157–1168. doi: 10.1093/neuros/nyz077
  99. Bauer AM, Rasmussen PA, Bain MD. Initial single-center technical experience with the brainpath system for acute intracerebral hemorrhage evacuation. Oper Neurosurg (Hagerstown). 2017;13: 69–76. doi: 10.1227/NEU.0000000000001258
  100. Du N, Wang X, Zhang X, et al. A new surgical method of treatment spontaneous intracranial hemorrhage. Transl Neurosci. 2021;12(1):145–153. doi: 10.1515/tnsci-2020-0164

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия  ПИ № ФС 77 - 86296 от 11.12.2023 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80632 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies